EA
CVS icon

Evolution Advisers’s CVS Health CVS Stock Holding History

Evolution Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+1
New +$89 ﹤0.01% 384

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Evolution Advisers's CVS Position: Q2 2026 in Review

Evolution Advisers opened a new position in CVS Health (CVS) in Q2 2026: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #384 among its holdings.

2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Evolution Advisers held 1 share of CVS Health worth $0 as of Q2 2026.
  • CVS Health was a new Evolution Advisers position in Q2 2026.
  • CVS Health made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #384 holding.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.